Takeda Pharmaceutical (TAK) Non Operating Income (2019 - 2023)
Takeda Pharmaceutical (TAK) posted quarterly Non Operating Income of -$938.9 million for Q3 2020, down 173.35% quarter-over-quarter from -$343.5 million in Q1 2020.
Takeda Pharmaceutical (TAK) Non Operating Income (2019 - 2023) Analysis & Trends
Takeda Pharmaceutical's Non Operating Income history runs 2 years deep, the most recent figure standing at -$938.9 million for Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.67 Bn | 42.71 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.34 Bn | 39.68 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.45 Bn | 19.79 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.79 Bn | 17.90 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.63 Bn | 15.24 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.28 Bn | 7.62 Bn | 397.90 Mn | -20.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -250.23 Mn |
| Mar 31, 2022 | -216.84 Mn |
| Sep 30, 2020 | -938.94 Mn |
| Mar 31, 2020 | -343.50 Mn |
| Mar 31, 2019 | -0.08 |